» Articles » PMID: 7691265

T-cell Regeneration After Bone Marrow Transplantation: Differential CD45 Isoform Expression on Thymic-derived Versus Thymic-independent Progeny

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 1993 Oct 15
PMID 7691265
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

To study the source of regenerated T cells after bone marrow transplantation (BMT), lethally irradiated thymectomized and thymus-bearing C57BL/6 (Thy 1.2+) mice were injected with syngeneic T-cell depleted bone marrow (TCD BM) cells and graded numbers of congenic B6/Thy 1.1+ lymph node (LN) cells. LN cell expansion was the predominant source for T-cell regeneration in thymectomized hosts but was minimal in thymus-bearing hosts. Analysis of T-cell receptor (TCR) expression on LN progeny showed a diverse V beta repertoire. Therefore, peripheral T-cell progenitors exist within V beta families, but expansion of these progenitors after BMT is downregulated in the presence of a functional thymus. CD4+ cells derived from BM versus LN in thymus-bearing hosts displayed differential CD44 and CD45 isoform expression. BM-derived cells were primarily CD45RB+CD44lo and LN derived cells were nearly exclusively CD45RB- CD44hi. In thymectomized hosts, BM, host, and LN CD4+ progeny were CD45RB- CD44hi. We conclude that T-cell regeneration via peripheral T-cell progenitors predominates in hosts lacking thymic function and gives rise to T cells that display a "memory" phenotype. In contrast, the ability to generate sizable populations of "naive" type T cells after BMT appears limited to the prethymic progenitor pool and could serve as a marker for thymic regenerative capacity.

Citing Articles

Lymphopenia and Mechanisms of T-Cell Regeneration.

Saidakova E Cell tissue biol. 2022; 16(4):302-311.

PMID: 35967247 PMC: 9358362. DOI: 10.1134/S1990519X2204006X.


Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure.

Manouchehri N, Salinas V, Rabi Yeganeh N, Pitt D, Hussain R, Stuve O Front Neurol. 2022; 13:854390.

PMID: 35432156 PMC: 9009145. DOI: 10.3389/fneur.2022.854390.


Cytomegalovirus in Haematological Tumours.

Alonso-Alvarez S, Colado E, Moro-Garcia M, Alonso-Arias R Front Immunol. 2021; 12:703256.

PMID: 34733270 PMC: 8558552. DOI: 10.3389/fimmu.2021.703256.


Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children.

Janeczko-Czarnecka M, Rybka B, Ryczan-Krawczyk R, Kalwak K, Ussowicz M Cent Eur J Immunol. 2021; 45(2):151-159.

PMID: 33456325 PMC: 7792432. DOI: 10.5114/ceji.2019.89843.


Optimal Delivery of Follow-Up Care After Allogeneic Hematopoietic Stem-Cell Transplant: Improving Patient Outcomes with a Multidisciplinary Approach.

Giaccone L, Felicetti F, Butera S, Faraci D, Cerrano M, Dionisi Vici M J Blood Med. 2020; 11:141-162.

PMID: 32523389 PMC: 7237112. DOI: 10.2147/JBM.S206027.